Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome

Fabien B. Vincent, Melissa Bubicich, Sarah Downie-Doyle, Fabienne Mackay, Eric F. Morand, Maureen Rischmueller

Research output: Contribution to journalLetterOtherpeer-review

Original languageEnglish
Pages (from-to)254-256
Number of pages3
JournalClinical and Experimental Rheumatology
Volume37
Issue number3
Publication statusPublished - 1 May 2019

Cite this

Vincent, Fabien B. ; Bubicich, Melissa ; Downie-Doyle, Sarah ; Mackay, Fabienne ; Morand, Eric F. ; Rischmueller, Maureen. / Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome. In: Clinical and Experimental Rheumatology. 2019 ; Vol. 37, No. 3. pp. 254-256.
@article{50a6a58b9498468aaa3069d8d990588f,
title = "Serum soluble Fas and Fas ligand (FasL) in primary Sj{\"o}gren's syndrome",
author = "Vincent, {Fabien B.} and Melissa Bubicich and Sarah Downie-Doyle and Fabienne Mackay and Morand, {Eric F.} and Maureen Rischmueller",
year = "2019",
month = "5",
day = "1",
language = "English",
volume = "37",
pages = "254--256",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
number = "3",

}

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome. / Vincent, Fabien B.; Bubicich, Melissa; Downie-Doyle, Sarah; Mackay, Fabienne; Morand, Eric F.; Rischmueller, Maureen.

In: Clinical and Experimental Rheumatology, Vol. 37, No. 3, 01.05.2019, p. 254-256.

Research output: Contribution to journalLetterOtherpeer-review

TY - JOUR

T1 - Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome

AU - Vincent, Fabien B.

AU - Bubicich, Melissa

AU - Downie-Doyle, Sarah

AU - Mackay, Fabienne

AU - Morand, Eric F.

AU - Rischmueller, Maureen

PY - 2019/5/1

Y1 - 2019/5/1

UR - http://www.scopus.com/inward/record.url?scp=85071646632&partnerID=8YFLogxK

M3 - Letter

VL - 37

SP - 254

EP - 256

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3

ER -